Skip to content

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

Improving Breast Cancer Patients' Self-Efficacy and Sexual Health Quality of Life

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07434817
Enrollment
200
Registered
2026-02-27
Start date
2027-01-01
Completion date
2028-01-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Females, Newly Diagnosed Breast Cancer

Keywords

English and Spanish Speaking

Brief summary

Approximately 200 English- or Spanish-speaking women newly diagnosed with stage I-III breast cancer will be randomized to either receive access to an online sexual health video series or receive usual care. Participants will complete surveys at baseline and every two months for six months, measuring self-efficacy in patient-provider communication and perceived barriers to discussing sexual health. Electronic health record review will assess utilization of sexual-health-related medical and supportive services. A subset of participants will participate in qualitative interviews to explore their sexual health experiences during treatment and, for those receiving the intervention, the perceived impact of the videos.

Interventions

BEHAVIORALSexual Health Educational Video Series

Participants randomized to the intervention arm will receive multiprong access to the videos, including a link provided through email and the recruitment sites' patients portal, a QR code, and tablets available in each clinic.

OTHERStandard Care (in control arm)

Standard Care

Sponsors

University of Colorado, Denver
Lead SponsorOTHER
Cancer League of Colorado
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision to sign and date the consent form. * Stated willingness to comply with all study procedures and be available for the duration of the study. * Age minimum 18 * Be a female as assigned on birth certificate * Ability to read and speak English or Spanish * A recent diagnosis of Stage 1-III invasive breast cancer and receiving treatment for breast cancer at the University of Colorado or Denver Health breast center(s).

Exclusion criteria

* Age less than 18 years old * Stage 0 or Stage IV breast cancer * Prior breast cancer diagnosis * Non-breast cancer diagnoses * Prior exposure to anti-hormone therapy, chemotherapy, or radiotherapy not related to breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Participant self-efficacy discussing sexual health with breast cancer providersBaseline, 2 months, 4 months, 6 monthsChanges in participant self-efficacy to discuss sexual health with breast cancer providers will be assessed using the Perceived Efficacy in Patient-Physician Interactions (PEPPI-5), administered at enrollment and every two months over a six-month period. The PEPPI-5 is a 5-item measure scored on a 5-point Likert scale, with higher scores indicating greater perceived self-efficacy in communicating with healthcare providers.
Perceived barriers to discussing sexual health with breast cancer providersBaseline, 2 months, 4 months, 6 monthsMeasured using the 13-item Barriers to Sexual Health Communication (BSHC) scale. Items are rated on a 5-point Likert scale; higher scores reflect greater perceived communication barriers.

Secondary

MeasureTime frameDescription
Use of medical and supportive services outside of treatment-plan related visits12 monthsParticipant use of medical and supportive services outside of treatment-plan-related visits will be assessed through electronic health record review from enrollment through 12 months of follow-up. Services of interest will include supportive care, behavioral health, sexual health, rehabilitation, and other ancillary services. Self-reported data collected at enrollment will capture utilization of relevant medical and supportive services in the period prior to study participation.
Qualitative measure: Patient-reported experiences with sexual health and perceived impact of the video content.One time, 60 minute interview, 6-12 months after enrollmentPatient sexual health will be assessed qualitatively through semi-structured interviews with a subset of participants at six months following breast cancer diagnosis. Interviews will explore participants' experiences with sexual health concerns and evaluate how the video content did or did not influence their knowledge, communication, coping, and perceived support related to sexual health during treatment and survivorship.

Countries

United States

Contacts

CONTACTSarah Leslie, MPH
Sarah.Leslie@cuanschutz.edu303-724-8995
CONTACTSarah Tevis, MD
sarah.tevis@cuanschutz.edu303-724-2750
PRINCIPAL_INVESTIGATORSarah Tevis

University of Colorado, Denver

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026